| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Diseases > Anemia - Causes, Symptoms and Treatment |
|
E-Articles - Anemia - Causes, Symptoms and Treatment
Anemia is a condition where there is a lower than normal number of red blood cells in the blood, usually measured by a decrease in the amount of hemoglobin. " It is a common proble According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product m for cancer patients and often results from the therapies used to suppress or control tumors. Anemia is associated with fatigue - a feeling of weakness or diminished physical and ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ental capacity unrelieved by rest (fatigue). Additional symptoms include diminished ability to perform daily functions and possibly impaired cognitive function, headache, dizziness lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. chest pain and shortness of breath, nausea, depression and occasionally pain. These symptoms are often complicated by coexisting disease(s). There are many compromises that are n here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe cessary when one has symptomatic anemia. This can affect the tolerability of therapy. Anemia is also associated with a poorer prognosis and increased mortality. Anemia is a common d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro lood disorder. Women and people with chronic diseases are at increased risk of the condition. If you suspect you have anemia, see your doctor. Anemia can be a sign of serious illne ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ses. Treatments for anemia range from taking supplements to undergoing medical procedures. Although there are over 400 different forms of anemia, this health profile will only addr easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ss the three most common: iron-deficiency anemia, vitamin B12 anemia and folic acid deficiency. Anemias can also be caused by such conditions as external bleeding, chronic disease, nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically pregnancy , alcoholism, bleeding disorders, infection and hereditary conditions Causes of Anemia Except for the acute form, anemia is a result of systemic toxemia and acidosis-a and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ondition of poisons, toxins and accumulated waste products floating in the blood - and lymph-streams, and of enervation or lowered nerve-tone. There is either an accumulation of th ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi se injurious substances due to failure of eliminative organs to handle a normal amount of such products, or they are produced in such considerable quantities that even normal organ ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a s, eliminating a normal amount or more than a normal amount of eliminations can not remove them rapidly enough. They have the effect of poisoning the organs that make the blood cel dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod s, which produce a deficient amount of blood cells or altered blood cells. Symptoms of Anemia Anemia goes undetected in many people, and symptoms can be vague. Most commonly, peo cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin le with anemia report a feeling of weakness or fatigue, general malaise and sometimes a poor concentration. People with more severe anemia often report dyspnea (shortness of breath tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen on exertion. Very severe anemia prompts the body to compensate by increasing cardiac output , leading to palpitations and sweatiness, and to heart failure . Other useful signs are t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel cheilosis and koilonychia . Treatment of Anemia Treatment should be directed at the cause of the anemia. In some cases, blood transfusions and the medication erythropoietin will ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust orrect anemia. For example, treatment for sickle cell anemia is different than treatment for a diet low in iron or folic acid. Talk to your HCP about the best treatment for the cau y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products e of your anemia. Other Treatment Injectable EPO (e.g., PROCRIT®, EPOGEN®) is an alternative to blood transfusion to treat critically ill patients with anemia. Exogenous EPO is ide . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de tical to the natural hormone in its role of stimulating the bone marrow to produce red blood cells. EPO has been used safely in many clinical settings, including chronic renal fail elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip re, oncology, and surgery. In the ICU, use of EPO has been shown to reduce the amount of blood transfused by almost 50%, at the same time significantly increasing hemoglobin levels tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How To Start Getting Impressive Traffic From Day One If You Have Diabetes, You May Be Entitled To No Cost Diabetic Supplies
|